Spontaneous delayed recovery of perfusion after thrombolyzed acute myocardial infarction: is it predictable before

B A Samad1, J Höjer, F Bouvier

  • 1Karolinska Institutet, Department of Cardiology, Stockholm Söder Hospital, Stockholm, Sweden. Samad@medklin.sos.sll.se

Insights

Predischarge low-dose dobutamine echocardiography accurately predicts late recovery of myocardial perfusion after acute myocardial infarction. This non-invasive imaging technique helps assess spontaneous recovery of left ventricular function post-thrombolysis.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Nuclear Medicine

Background:

  • Assessing final infarct size after thrombolyzed acute myocardial infarction is challenging due to delayed left ventricular recovery.
  • Early prediction of spontaneous perfusion and function recovery is crucial for patient management.

Purpose of the Study:

  • To evaluate the efficacy of predischarge low-dose dobutamine echocardiography in predicting late recovery of myocardial perfusion.
  • To correlate echocardiographic findings with single-photon emission computed tomography (SPECT) results.

Main Methods:

  • Prospective study of 53 patients with acute myocardial infarction treated with thrombolysis.
  • Low-dose dobutamine echocardiography and (99m)Tc-sestamibi SPECT performed early post-infarction.
  • Follow-up SPECT at 6 months to assess myocardial recovery defined by a >10% reduction in SPECT defect size.

Main Results:

  • Significant improvement in left ventricular wall motion score index during dobutamine echocardiography predicted late perfusion recovery (Group 1).
  • Patients with significant SPECT defect reduction (Group 1) showed improved wall motion score index (1.62 to 1.41, P <.001).
  • Patients without significant perfusion recovery (Group 2) showed no significant change in wall motion score index.

Conclusions:

  • Predischarge low-dose dobutamine echocardiography is a reliable predictor of late spontaneous recovery of myocardial perfusion post-acute myocardial infarction.
  • This imaging modality aids in assessing the potential for functional recovery in treated patients.
  • Useful for guiding further therapeutic strategies and prognostication.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...